Tag: Venous
Vascular News’ top 10 most popular stories of September 2024
Six-month data from Merit Medical's Wrapsody WAVE trial, an update on the NHS England Acute Aortic Dissection Toolkit, and a large meta-analysis of endovascular...
Spectrum Program highlights VenaSeal closure system’s importance in treating superficial venous...
“I would challenge anybody who says that VenaSeal is investigational. It’s a robust, well-evaluated, very well studied intervention that I think we would all...
European registry set to raise the evidence bar for deep venous...
The pilot phase of a new European Venous Registry (EVeR)—designed to illuminate the real-world outcomes of deep venous interventions over a 10-year time horizon—is...
CX 2023 seeks consensus in “rapidly” progressing venous field
The CX 2023 Venous & Lymphatic programme is set to be a “highlight” of this year’s meeting, CX co-chair and executive board member Erin...
Truveta announces collaboration with Boston Scientific to advance post-procedure patient insights...
Truveta announced a strategic collaborative agreement with Boston Scientific to improve long-term patient care and gain insights into healthcare disparities. Through this collaboration, Boston...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
Argon Medical launches novel innovations for portal vein access procedures
Argon Medical Devices has announced the launch of two portal vein access sets intended for transjugular liver access in diagnostic and interventional procedures.
The Scorpion...
ATTRACT fails to meet primary endpoint, but experts agree results are...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
Endovenous laser therapy of saphenous vein reflux using thulium laser with...
In this clinical study the one-year results of the endovenous laser therapy (ELT) application of 1,940nm laser (Vela XL, Boston Scientific) with respect to...
The success of deep venous intervention rests on mid- to long-term...
In this interview, Vascular News speaks to Prakash Saha, King’s College Hospital, London, UK, about the growth of deep venous treatment and how the...
WAVES trial shows 100% vein closure at one month with short...
A post-market evaluation of the VenaSeal closure system (Medtronic) has found that, at one month, 100% of treated veins remained closed, quality of life...
Varithena earns FDA approval for 30-day post-activation shelf life
BTG has announced that the US Food and Drug Administration (FDA) has approved an extension of the post-activation shelf life of Varithena (polidocanol injectable foam)...
